Clydebridge Group Limited


Directors	Jacob Froggett
	Martin Pisacane


Registered Address	7 Darwin Close
	Reading
	RG2 0TB


Registered Number	11331326 (England and Wales)

Balance Sheet as at
31 December 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Investments	3		1,400,000		1,400,000
			1,400,000		1,400,000
Total assets less current liabilities			1,400,000		1,400,000
Net assets			1,400,000		1,400,000
Capital and reserves
Called up share capital			1,400,000		1,400,000
Shareholders' funds			1,400,000		1,400,000

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 29 October 2026, and are signed on its behalf by:

Jacob Froggett
Director

Martin Pisacane
Director

Registered Company No. 11331326

Clydebridge Group Limited

Notes to the Financial Statements
for the year ended 31 December 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Going concern
	The financial statements have been prepared on a going concern basis.

	Investments
	Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment. Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	2		2

3.	Fixed asset investments
	Clydebridge Group Limited holds 100% of the voting rights and nominal value of the ordinary class of share capital of Clydebridge Chemicals Limited who's registered office is 7 Darwin Close, Reading, Berkshire, England & Wales. The proportion of voting rights and shares held was 100% in both 2025 and 2024.

	Investments in groups¹	Total
	£	£
Cost or valuation
At 01 January 25	1,400,000	1,400,000
At 31 December 25	1,400,000	1,400,000
Net book value
At 31 December 25	1,400,000	1,400,000
At 31 December 24	1,400,000	1,400,000

	Notes
	¹Investments in group undertakings and participating interests